Martin Augsten
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 3
- Oncology 15
- Cancer Cells and Metastasis 7
- Chemokine receptors and signaling 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Arne Östman (15 shared papers)Lars Egevad (6 shared papers)Elin Sjöberg (5 shared papers)Eleonor Olsson (4 shared papers)Christina Hägglöf (4 shared papers)Arne Östman (3 shared papers)Helene Rundqvist (4 shared papers)Åke Borg (2 shared papers)
- Journals
- Cancer Research (5 papers)Proceedings of the National Academy of Sciences (2 papers)Cell Death and Disease (2 papers)Cell Death Discovery (1 paper)Infection and Immunity (1 paper)
- Partner nations
- SwedenGermanyUnited States
In The Last Decade
Martin Augsten
29 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 107
- Oncology 1.2k
- Cancer Research 594
- Immunology 559
- Molecular Biology 1.1k
- Cell Biology 215
Countries citing papers authored by Martin Augsten
This map shows the geographic impact of Martin Augsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Augsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Augsten more than expected).
Fields of papers citing papers by Martin Augsten
This network shows the impact of papers produced by Martin Augsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Augsten. The network helps show where Martin Augsten may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Augsten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 444 | |
| 2 | 2014 | 357 | |
| 3 | 2009 | 202 | |
| 4 | 2018 | 176 | |
| 5 | 2012 | 148 | |
| 6 | 2014 | 119 | |
| 7 | 2014 | 109 | |
| 8 | 2017 | 100 | |
| 9 | 2013 | 91 | |
| 10 | 2010 | 89 | |
| 11 | 2019 | 87 | |
| 12 | 2013 | 86 | |
| 13 | 2020 | 81 | |
| 14 | 2016 | 74 | |
| 15 | 2005 | 73 | |
| 16 | 2016 | 58 | |
| 17 | 2013 | 51 | |
| 18 | 2012 | 50 | |
| 19 | 2014 | 49 | |
| 20 | 2019 | 37 |
About Martin Augsten
Martin Augsten is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 30 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Chemokine receptors and signaling (5 papers), Immune cells in cancer (4 papers), Cancer-related Molecular Pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (594 citations), Immunology (559 citations), Molecular Biology (1.1k citations) and Cell Biology (215 citations). Martin Augsten has collaborated with scholars based in Sweden, Germany and United States. Frequent co-authors include Arne Östman, Lars Egevad, Elin Sjöberg, Eleonor Olsson, Christina Hägglöf, Arne Östman, Helene Rundqvist, Åke Borg, Jeroen Frijhoff and Panagiotis Tsagozis. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Cell Death and Disease, Cell Death Discovery and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.